Allecra Therapeutics
France - Saint LouisBiotechnology
Focus: Allecra Therapeutics is a France-based biotechnology company focused on treating multi-drug-resistant bacterial infections, a critical unmet medical need in infectious diseases. The company operates as a focused biotech with a lean pipeline targeting serious bacterial pathogens.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Open Jobs
0
About Allecra Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Allecra Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Phase 1
Clinical Trials (5)
NCT03687255Safety and Efficacy Study of Cefepime-AAI101 in the Treatment of Complicated Urinary Tract Infections
Phase 3Help build intelligence for Allecra Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.